AKT1 and prostate cancer: Similarly, Agell et al. [47] found a strong correlation between high intensity of p-AKT (Ser473) immunoexpression and PIK3CA RNA overexpression and/or genomic copy number gain in 21 prostate cancer cases (p<0.0001).